Differential Antiplatelet Effects of Various Glycoprotein IIb–IIIa Antagonists
- 15 January 2001
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 101 (2), 53-64
- https://doi.org/10.1016/s0049-3848(00)00385-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Clinical Outcomes of Therapeutic Agents That Block the Platelet Glycoprotein IIb/IIIa Integrin in Ischemic Heart DiseaseCirculation, 1998
- Evaluation of a GPIIb/IIIa antagonist YM337 in a primate model of middle cerebral artery thrombosisEuropean Journal of Pharmacology, 1998
- Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic StrategyCirculation, 1995
- Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular MedicineNew England Journal of Medicine, 1995
- Platelet lntegrinsThrombosis and Haemostasis, 1995
- Pathology of arterial thrombosisBritish Medical Bulletin, 1994
- Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIaBiochemical Journal, 1994
- Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodiesBlood, 1990
- The platelet membrane glycoprotein IIb-IIIa complexBlood, 1988
- Anonymous Correspondents of the LancetBMJ, 1844